Skip to main content

O'Melveny & Myers, Tian Yuan Law Firm and William Ji & Co. have represented China’s Simcere Pharmaceutical Group on its HK$3.57 billion ($460.6 million) Hong Kong IPO, with Herbert Smith Freehills and Jingtian & Gongcheng advising the joint sponsors.

The listing is the latest by a Chinese biopharmaceutical company in Hong Kong, which is on track to have its second-busiest year for equity capital markets ever in 2020. Recent such issuers include JHBP (CY) Holdings and Everest Medicines.

Simcere Pharmaceutical supplies branded generic pharmaceuticals to the Chinese market. It has increased investment in R&D in recent years, and has three R&D centres in Nanjing, Shanghai and Boston.

Partners Matt Emsley, Siddhartha Sivaramakrishnan and Stanley Xie led the Herbert Smith Freehills team.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

CC, DFDL, Bakers, HBS act on $550 mln Cambodia microfinance deal

by Asian Legal Business《亚洲法律杂志》 |

Magic Circle law firm Clifford Chance and DFDL have advised a consortium of investors on the $550 million sale of Cambodian microfinance institution Amret to Taiwan's Bank SinoPac, which was represented by Baker McKenzie Taiwan and local firm HBS Law.

Deals

A&O Shearman guides $1.2 bln Malaysian data centre deal

by Nimitt Dixit |

Global law firm A&O Shearman has advised Malaysian real estate firm Sime Darby Property (SDP) on a $1.2 billion agreement to develop and lease a data centre campus in Malaysia with Google-backed Pearl Computing Malaysia.

Deals

CC, Milbank, Rahmat Lim, Zul Rafique advise on $900 mln M’sia data centre financing

by Asian Legal Business《亚洲法律杂志》 |

Clifford Chance and Rahmat Lim & Partners have represented data centre developer Yondr Group in securing over $900 million in project financing for its hyperscale data centre in Johor, Malaysia. Milbank advised the finance partie